Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Mechanism of Action of Collagen and Epidermal Growth Factor: A Review on Theory and Research Methods
Mohamad Hesam Shahrajabian, Wenli Sun
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 4, pp. 453-477
Closed Access | Times Cited: 32
Repositioning Cannabinoids and Terpenes as Novel EGFR-TKIs Candidates for Targeted Therapy Against Cancer: A virtual screening model using CADD and biophysical simulations
Ossama Daouı, Suraj N. Mali, Kaouakeb Elkhattabi, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15545-e15545
Open Access | Times Cited: 16
Exploring the Efficacy and Target Genes of Atractylodes Macrocephala Koidz Against Alzheimer’s Disease Based on Multi-Omics, Computational Chemistry, and Experimental Verification
Yuanteng Zheng, Xin Gao, Jiaqi Tang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 118-118
Open Access
UHPLC-Q Exactive-Orbitrap-MS and network pharmacology analyses to investigate the mechanism by which Danggui-Shaoyao-San affects 27-OHC-induced cell damage in SH-SY5Y/C6 coculture
Yi Huang, Yingying Zhai, Di Zhao, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer’s Disease
Shubham Nilkanth Rahmatkar, Damanpreet Singh
Molecular Neurobiology (2025)
Closed Access
ANXA2 Protein and Its Role in Neurodegeneration Processes
Suzanna A. Partevian, P. A. Slominsky, М. И. Шадрина, et al.
Life (2025) Vol. 15, Iss. 3, pp. 402-402
Open Access
Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3 β in Alzheimer’s disease
Hitesh Kumar, Ashok Kumar Datusalia, Anoop Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-14
Closed Access
Activation of GPER1 alleviates white matter injury by promoting microglia M2 polarization through EGFR/Stat3 pathway in intracerebral hemorrhage mice
Xuyang Zhang, Jianchao Mao, Huanhuan Li, et al.
Journal of Stroke and Cerebrovascular Diseases (2025), pp. 108315-108315
Open Access
Miracle fruit seed as a potential supplement for the treatment of learning and memory disorders in Alzheimer’s disease
Xueyan Huang, Lu‐Lu Xue, Ting‐Bao Chen, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 9
miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach
Jéssica Diniz Pereira, Lívia Cristina Ribeiro Teixeira, Izabela Mamede, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 6, pp. 977-994
Closed Access | Times Cited: 3
Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer’s Disease
Samat Kozhakhmetov, Aiym Kaiyrlykyzy, Zharkyn Jarmukhanov, et al.
International Journal of Alzheimer s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Bioinformatics analysis of the potential receptor and therapeutic drugs for Alzheimer’s disease with comorbid Parkinson’s disease
Xue‐Rong Zhou, Z X Liu, Guiqin Bai, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Genome‐wide meta‐analysis identifies ancestry‐specific loci for Alzheimer's disease
Yi‐Jun Ge, Shi‐Dong Chen, Bang‐Sheng Wu, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6243-6256
Open Access | Times Cited: 2
Plasma proteomics for risk prediction of Alzheimer's disease in the general population
Sisi Yang, Ziliang Ye, Panpan He, et al.
Aging Cell (2024)
Open Access | Times Cited: 2
Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer’s Disease
Sian Jin, Xuefeng Guan, Dongyu Min
Current Alzheimer Research (2023) Vol. 20, Iss. 8, pp. 588-602
Open Access | Times Cited: 5
Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease
Xin Wang, Yi Qu, Jiayu Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation
Meng Yu, Zhongqi Shen, Shaozhi Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33761-e33761
Open Access | Times Cited: 1
Computational Fragment‐Based Design of Phytochemical Derivatives as EGFR Inhibitors
S Gayathri, Fayaz Shaik Mohammad
Chemistry & Biodiversity (2023) Vol. 20, Iss. 8
Open Access | Times Cited: 3
Mechanism of Polygala-Acorus in Treating Autism Spectrum Disorder Based on Network Pharmacology and Molecular Docking
Haozhi Chen, Changlin Zhou, Wen Li, et al.
Current Computer - Aided Drug Design (2024) Vol. 20, Iss. 7, pp. 1087-1099
Open Access
Galectin-3 and its associated molecular partners in the emergence and progression of cardiometabolic disorders
Praveenkumar Shetty, Pavan K. Jayaswamy, Prakash Patil, et al.
Elsevier eBooks (2024), pp. 159-182
Closed Access
Exploring the therapeutic potential of marine actinomycetes: a systems biology-based approach for Alzheimer’s disease treatment
Mayank Roy Chowdhury, Moni Philip Jacob Kizhakedathil, Vinith Kumar, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Bioorthogonal Synthesis of Biomimetic Nanoparticles for Screening Chemical Hazards in Food Samples
Qianyu Li, Jianghua Liu, Zihe Qi, et al.
Analytical Chemistry (2024) Vol. 97, Iss. 1, pp. 247-254
Closed Access
Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment
Seda Şirin, Serap Niğdelioğlu Dolanbay
Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi (2024)
Open Access
Exploring molecular mechanisms of diazinon toxicity in HT22 hippocampal neurons through integrated miRNA and mRNA profiling
Jianan Li, Yan Sun, Haoran Bi
Computers in Biology and Medicine (2024) Vol. 182, pp. 109091-109091
Closed Access
Page 1 - Next Page

Scroll to top